|
 |
|
|
|||
|
 |
|
Nov. 5, 2026 Source: Nutrien news release SASKATOON, Saskatchewan -- Nutrien Ltd. (TSX and NYSE: NTR) announced today its third quarter 2026 results, with net earnings of $0.29 billion ($0.60 diluted net earnings per share). Third quarter 2026 adjusted EBITDA1 was $1.31 billion and adjusted net earnings per share1 was $0.61. In the first nine months of 2026, we generated net earnings of $1.65 billion and adjusted EBITDA1 of $4.85 billion. "Nutrien delivered structural earnings growth and increased cash returns to shareholders in the first nine months of 2026, supported by record potash sales volumes, strong proprietary products gross margins and a continued focus on operational excellence," commented Ken Seitz, Nutrien's President and CEO. "We have taken decisive actions on our portfolio optimization initiatives that will enhance earnings quality and support long-term growth in free cash flow per share." Highlights: *Retail adjusted EBITDA increased to $1.44 billion in the first nine months of 2026 due to higher proprietary products gross margins and a strong livestock market in Australia, partially offset by lower crop nutrient sales volumes and higher fuel costs. *Potash adjusted EBITDA increased to $1.97 billion in the first nine months of 2026 due to higher global benchmarks and strong operational and supply chain execution that supported record sales volumes. *Nitrogen adjusted EBITDA decreased to $1.61 billion in the first nine months of 2026 due to lower sales volumes, partially offset by higher global nitrogen benchmarks and lower natural gas costs. Production from our low-cost North American nitrogen plants was consistent with our plan, including execution of planned turnarounds at three nitrogen sites. *Cash provided by operating activities increased by 17 percent in the first nine months of 2026. We returned $1.3 billion to shareholders in the first nine months of 2026 through dividends and share repurchases, including a 36 percent increase in share repurchases. We repurchased approximately $83 million of common shares in the fourth quarter as of November 3, 2026. 1 This is a non-GAAP financial measure. See the "Non-GAAP Financial Measures" section. All references to per share amounts pertain to diluted net earnings per share, unless otherwise noted. 2 Our discussion of highlights set out on this page is a comparison of the results for the nine months ended September 30, 2026 to the results for the nine months ended September 30, 2025, unless otherwise noted. Strategic Actions: Consistent with our aim to simplify our portfolio and focus on core assets that enhance earnings quality and free cash flow, we completed a comprehensive review of strategic alternatives for our Phosphate business. Following this review, we have determined the optimal path in the current environment is to retain and further optimize our Aurora and integrated upgrade facilities, while shutting down operations at our White Springs facility in the second quarter of 2027. We believe these actions best position Nutrien to enhance shareholder value. To read the entire report click here. Tweet |
|
|
|
|
|
|
|
|
|||||||||||||
